Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.95 +0.43 (+1.46%)
As of: Sep 30, 2026 · 12:18 PM EDT

Lakefront Biotherapeutics NV (LKFT) Convertible Debt (2013 - 2026)

Updated

Lakefront Biotherapeutics' Convertible Debt was $25.26 million in the quarter ended Mar 31, 2026, down 29.8% from $35.97 million a year earlier but up 2.5% from the prior quarter.

Analysis

Lakefront Biotherapeutics NV (LKFT) Convertible Debt (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Convertible Debt at Lakefront Biotherapeutics came in at $23.92 million.

  • Quarterly Convertible Debt has moved between $23.03 million (the quarter ended Jun 30, 2025) and $35.97 million (the quarter ended Mar 31, 2025) over five years.
  • Per Business Quant data, LKFT's Convertible Debt in the three quarters before the quarter ended Mar 31, 2026 was $24.65 million (quarter ended Dec 31, 2025), $24.28 million (quarter ended Sep 30, 2025) and $23.03 million (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 25.26 Mn
Dec 31, 2025 24.65 Mn
Sep 30, 2025 24.28 Mn
Jun 30, 2025 23.03 Mn
Mar 31, 2025 35.97 Mn
Sep 30, 2018 66,298.36
Jun 30, 2018 69.22 Mn
Mar 31, 2018 79,854.63
Dec 31, 2017 76,533.11
Jun 30, 2017 62,674.31
Mar 31, 2017 68,186.04
Dec 31, 2016 68,022.63
Jun 30, 2016 57,623.63
Dec 31, 2015 60,286.45
Dec 31, 2014 89,988.01
Apr 1, 2014 -827,668.30
Dec 31, 2013 909,207.83
API Access

Lakefront Biotherapeutics NV Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=LKFT&period=max&api_key=YOUR_API_KEY